A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)

Clinical trial NCT00394186 · COMPLETED

Trial details

NCT number: NCT00394186
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome (IBS)

Start date: 2006-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.